Recently, a family of
phospholipid mediators has received much attention because of its variety of
biological activities.
Lysophosphatidic acid (LPA) is a central member of the
phospholipid autacoid family that exerts diverse effects through binding to and activation of several specific receptors coupled to
G-proteins. In accordance with its function as a receptor agonist, there are pathways for extracellular generation of LPA in vivo. One pathway involves a novel
lysophospholipase D activity that was originally found in rat plasma. LPA is also produced in significant amounts after incubation of various plasma-derived body fluids such as human follicular fluid at 25-37 degrees C. In animal models, LPA was shown to stimulate oocyte maturation, embryonic development and transport in the oviduct. An increase in serum
lysophospholipase D activity was observed during pregnancy in human. These results suggest that LPA generated by
lysophospholipase D is likely to play an important role in reproductive biology. LPA produced by
lysophospholipase D activity in body fluids has also been observed under pathophysiological conditions: serum and ascitic fluid from
ovarian cancer patients and serum from hypercholesterolemic rabbits. Hence, excess generation of LPA by
lysophospholipase D activity in body fluids has been suggested to be relevant to the pathogenesis of
cancer and
atherosclerosis.